Publications by authors named "Aslihan Avanoglu Guler"

Claim this Profile
I
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry.
Laura Calabrese, Alessandra Cartocci, Antonio Vitale, Eduardo Martín-Nares, Martina D'Onghia, Aslihan Avanoglu Guler

Clin Exp Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of MEFV mutations and HLA-B27 on clinical findings of familial Mediterranean fever and spondyloarthritis.
Tuba Yuce Inel, Aslihan Avanoglu Guler, Nazife Sule Yasar Bilge, Timucin Kasifoglu, Abdurrahman Tufan

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness.
Hazan Karadeniz, Sevcihan Kesen, Mert Burak Akhan, Serkan Unlu, Rıza Can Kardas, Aslıhan Avanoglu Guler

Hellenic J Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of potential prothrombotic state markers in Behçet's disease and correlation with vascular ultrasound.
Hazan Karadeniz, Tunjay Mammadov, Mahi Nur Cerit, Rıza Can Kardas, Aslıhan Avanoglu Guler

Ir J Med Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.
Gizem Tuğçe Alp, İbrahim Vasi, Emre Alp, Aslıhan Avanoğlu Güler, Hazan Karadeniz

Biomark Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of self-management program performed via telerehabilitation on occupational performance and satisfaction of individuals with systemic sclerosis.
Emirhan Karakuş, Fulden Sari, Aslıhan Avanoğlu Güler, Deran Oskay, Çiğdem Öksüz

Br J Occup Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Telerehabilitation-Based Self-Management Programme on Individuals With Scleroderma.
Emirhan Karakuş, Fulden Sari, Aslıhan Avanoğlu Güler, Deran Oskay, Çiğdem Öksüz

Musculoskeletal Care· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight.
Aslihan Avanoglu Guler, Giacomo De Luca, Lorenzo Dagna, Marco Matucci-Cerinic, Corrado Campochiaro

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin inhibitors in unplanned pregnancies with active lupus disease: A retrospective observational study.
İbrahim Vasi, Derya Yıldırım, Rıza Can Kardaş, Burcugül Kaya, Rahime Duran

Int J Clin Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' hands.
Aslihan Avanoglu-Guler, Corrado Campochiaro, Giacomo De Luca, Michael Hughes, Abdurrahman Tufan

Semin Arthritis Rheum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.
İbrahim Vasi, Rıza Can Kardaş, Mustafa Ekici, Derya Yıldırım, Burcugül Kaya

Int J Rheum Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of sarcopenia in Turkish women with systemic lupus erythematosus.
Reyhan Bilici, Burcu Candemir, Hasan Satış, Gizem Tuğçe Alp, Funda Yıldırım Borazan, Aslihan Avanoglu Guler

Lupus Sci Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.
Aslıhan Avanoglu Güler, Büşra Özçimen, Mesude Seda Aydoğdu, Alper Sari, Aliyeva Numune

Turk J Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?
İbrahim Vasi, Rıza Can Kardaş, Derya Yıldırım, Burcugül Kaya, Rahime Duran

Int J Clin Pharmacol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.
Derya Yildirim, Riza Can Kardas, Mert Gun, Burcugul Kaya, Ibrahim Vasi, Aslihan Avanoglu Guler

Int Immunopharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of interleukin-1 antagonists on de novo and pre-existing damage in patients with familial Mediterranean fever.
Derya Yildirim, Burcugul Ozkiziltas, Ibrahim Vasi, Hazan Karadeniz, Aslihan Avanoglu Guler

Clin Exp Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study.
Hazan Karadeniz, Murat Ucar, Tunjay Mammadov, Leyla Salimli Mirzayeva, Aslıhan Avanoglu Guler

Semin Arthritis Rheum· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis.
Hazan Karadeniz, Mahinur Cerit, Aslıhan Avanoğlu Güler, Abdurrahman Tufan, Yogen Kanthi

Rheumatology (Oxford)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
Aslihan Avanoglu Guler, Tuba Yuce Inel, Timucin Kasifoglu, Cansu Coskun, Hazan Karadeniz

Mod Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjögren's syndrome.
Hazan Karadeniz, Mahinur Cerit, Aslıhan Avanoğlu Güler, Reyhan Bilici Salman, Hasan Satış

Int J Rheum Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD.
Hazan Karadeniz, Aslihan Avanoğlu Güler, Rıza Can Kardaş, Muzaffer Karadeniz, Hatice Paşaoğlu

Turk J Med Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients.
Hazan Karadeniz, Aslıhan Avanoğlu Güler, Hasan Selçuk Özger, Pınar Aysert Yıldız, Gonca Erbaş

Biomark Insights· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome.
Jurgen Sota, Antonio Vitale, Ewa Więsik-Szewczyk, Micol Frassi, Giuseppe Lopalco, Aslihan Avanoglu Guler

Front Med (Lausanne)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis.
Nuh Atas, Bağdagül Çakır, Fatih Bakır, Murat Uçar, Hasan Satış

Clin Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients.
Hazan Karadeniz, Emetullah Cindil, Hakan Babaoğlu, Aslıhan Avanoğlu Güler, Reyhan Bilici Salman

Eur J Rheumatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis